Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Effects of genetic variation on chromatin structure and the transcriptional machinery: analysis of the IL6 gene locus.

Smith AJ, Zheng D, Palmen J, Pang DX, Woo P, Humphries SE.

Genes Immun. 2012 Oct;13(7):583-6. doi: 10.1038/gene.2012.32. Epub 2012 Aug 16.

PMID:
22895491
2.

Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism.

Smith AJ, D'Aiuto F, Palmen J, Cooper JA, Samuel J, Thompson S, Sanders J, Donos N, Nibali L, Brull D, Woo P, Humphries SE.

Clin Chem. 2008 May;54(5):841-50. doi: 10.1373/clinchem.2007.098608. Epub 2008 Mar 20.

3.

Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.

Gautam KA, Muktanand T, Sankhwar SN, Goel A, Sankhwar PL, Rajender S.

Cytokine. 2016 Jan;77:152-6. doi: 10.1016/j.cyto.2015.11.008. Epub 2015 Nov 19.

PMID:
26605964
4.

Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery.

Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE.

Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1458-63.

5.

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.

Terry CF, Loukaci V, Green FR.

J Biol Chem. 2000 Jun 16;275(24):18138-44.

6.

Functional variants of IL4 and IL6 genes and risk of tobacco-related oral carcinoma in high-risk Asian Indians.

Gaur P, Mittal M, Mohanti B, Das S.

Oral Dis. 2011 Oct;17(7):720-6. doi: 10.1111/j.1601-0825.2011.01831.x. Epub 2011 Jul 20.

PMID:
21771210
8.

[Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels].

Titov BV, Barsova RM, Martynov MIu, Nikonova AA, Favorov AV, Gusev EI, Favorova OO.

Mol Biol (Mosk). 2012 Jan-Feb;46(1):93-102. Russian.

PMID:
22642105
9.

Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: interactions with social position in the Whitehall II cohort.

Sanderson SC, Kumari M, Brunner EJ, Miller MA, Rumley A, Lowe GD, Marmot MG, Humphries SE.

Atherosclerosis. 2009 Jun;204(2):459-64. doi: 10.1016/j.atherosclerosis.2008.09.019. Epub 2008 Sep 27.

PMID:
19019369
10.

Association between interleukin 6 promoter variants and chronic hepatitis B progression.

Park BL, Lee HS, Kim YJ, Kim JY, Jung JH, Kim LH, Shin HD.

Exp Mol Med. 2003 Apr 30;35(2):76-82.

11.

Allele associations reveal four prominent haplotypes at the human interleukin-6 (IL-6) locus.

Jordanides N, Eskdale J, Stuart R, Gallagher G.

Genes Immun. 2000 Oct;1(7):451-5.

12.

Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty.

Gordon A, Kiss-Toth E, Stockley I, Eastell R, Wilkinson JM.

Arthritis Rheum. 2008 Oct;58(10):3157-65. doi: 10.1002/art.23863.

13.

Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.

San Luciano M, Ozelius L, Lipton RB, Raymond D, Bressman SB, Saunders-Pullman R.

Neurosci Lett. 2012 Jan 11;506(2):312-6. doi: 10.1016/j.neulet.2011.11.032. Epub 2011 Dec 1.

14.

Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment.

Mertens J, Ramadori G, Mihm S.

Hum Mol Genet. 2010 Dec 1;19(23):4587-94. doi: 10.1093/hmg/ddq386. Epub 2010 Sep 15.

PMID:
20846942
15.

A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.

Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M.

J Hum Genet. 2001;46(5):267-72.

PMID:
11355017
16.

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

Hamid YH, Rose CS, Urhammer SA, Glümer C, Nolsøe R, Kristiansen OP, Mandrup-Poulsen T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O.

Diabetologia. 2005 Feb;48(2):251-60. Epub 2005 Jan 11.

PMID:
15645209
17.

Association of interleukin-6 gene polymorphism (rs1800796) with severity and functional status of osteoarthritis in elderly individuals.

Fernandes MT, Fernandes KB, Marquez AS, Cólus IM, Souza MF, Santos JP, Poli-Frederico RC.

Cytokine. 2015 Oct;75(2):316-20. doi: 10.1016/j.cyto.2015.07.020. Epub 2015 Jul 29.

PMID:
26233477
18.

Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.

Visser M, Palstra RJ, Kayser M.

Hum Mol Genet. 2015 May 1;24(9):2649-61. doi: 10.1093/hmg/ddv029. Epub 2015 Jan 27.

PMID:
25631878
19.

The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study.

Zavaleta-Muñiz SA, Martín-Márquez BT, Gonzalez-Lopez L, Gonzalez-Montoya NG, Díaz-Toscano ML, Ponce-Guarneros JM, Ruiz-Padilla AJ, Vázquez-Del Mercado M, Maldonado-González M, Fafutis-Morris M, Flores-Martínez SE, Martínez-García EA, Gamez-Nava JI.

Clin Dev Immunol. 2013;2013:959084. doi: 10.1155/2013/959084. Epub 2013 Sep 23.

20.

Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women.

Chung HW, Seo JS, Hur SE, Kim HL, Kim JY, Jung JH, Kim LH, Park BL, Shin HD.

J Hum Genet. 2003;48(5):243-8. Epub 2003 Apr 18.

PMID:
12768442

Supplemental Content

Support Center